Singapore markets closed

Genscript Biotech Corporation (GNNSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.47000.0000 (0.00%)
At close: 10:09AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
839,529
839,529
625,698
490,096
390,846
Cost of revenue
429,976
429,976
321,615
207,578
134,953
Gross profit
409,553
409,553
304,083
282,518
255,893
Operating expenses
Research development
432,827
432,827
390,096
358,401
263,401
Selling general and administrative
387,739
387,739
350,811
302,477
197,682
Total operating expenses
808,623
808,623
731,839
651,730
447,886
Operating income or loss
-399,070
-399,070
-427,756
-369,212
-191,993
Interest expense
27,510
27,510
13,269
2,378
1,418
Income before tax
-350,979
-350,979
-431,690
-517,363
-281,900
Income tax expense
4,142
4,142
-3,719
964
-477
Income from continuing operations
-355,121
-355,121
-427,971
-518,327
-281,423
Net income
-95,477
-95,477
-226,851
-358,712
-204,945
Net income available to common shareholders
-95,477
-95,477
-226,851
-358,712
-204,945
Basic EPS
-0.09
-0.05
-0.11
-0.18
-0.11
Diluted EPS
-0.09
-0.05
-0.11
-0.18
-0.11
Basic average shares
2,105,161
2,109,365
2,097,135
2,030,598
1,900,787
Diluted average shares
2,105,161
2,109,365
2,097,135
2,030,598
1,900,787